ST
STE
Quarter ended Sep 30, 2024 · FY2025 Q2

STERIS (STE) Revenue — Quarter Ended Sep 30, 2024

Revenue increased this quarter, with growth both sequentially and compared to the same quarter last year.

Key takeaway

Quarter ended Sep 30, 2024 · FY2025 Q2

Revenue increased this quarter, with growth both sequentially and compared to the same quarter last year.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.3B

Revenue reported for this quarter.

Quarter-over-quarter

+3.9%

Change from the immediately preceding quarter.

Year-over-year

+7.3%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.3B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Dec 31, 2023$1.3B+6.7%
Mar 31, 2024$1.4B+10.8%
Jun 30, 2024$1.3B+8.1%
Sep 30, 2024$1.3B+7.3%

Revenue performance

The sequential rise reflects a continuing positive trend, while the year-over-year gain indicates sustained demand.

Quarterly comparison

Revenue was higher than the immediately preceding quarter and also exceeded the level from the same quarter one year earlier.

What to watch

The company has maintained year-over-year revenue growth in each of the past four quarters, based on the trend data provided.

STERIS (STE) Revenue — Quarter Ended Sep 30, 2024